← FDA DRUG APPROVALS

FDA ANDA · ANDA075811

MESNA

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA075811
TYPE
ANDA
ORIGINAL APPROVAL
2001-04-26
LATEST ACTION
2019-09-15
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MESNAPrescription
MESNA 100MG/ML · INJECTABLE · INTRAVENOUS

Approval history

2019-09-15Labeling · Supplement 14 · standardAP
2015-11-18Labeling · Supplement 12 · standardAP
2002-12-05Manufacturing (CMC) · Supplement 2AP
2002-05-13Manufacturing (CMC) · Supplement 1AP
2001-04-26OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →